The project “Back to Work”: mothers’ and fathers’ reintegration after the child-care leave” was presented at press-conference held on January 30 in Kyiv. The project is being implemented by League of Social Employees of Ukraine under the aegis of EU Representative Mission in Ukraine. Farmak JSC demonstrated the positive experience and practical realization of the parents’ rights in conditions of Ukrainian business.
Svitlana Tolstoukhova, President of All-Ukrainian Public Organization “League of Social Employees of Ukraine”:
“The main problem that is to be resolved within the framework of the project lays in the fact that fathers’ and mothers’ returning to work after the child-care leave is unfavorable. The employers unwillingly hire the young women expecting that they will give birth to a baby and take the child-care leave. The reason for such expectations is the employer’s uncertainty in adequate professional competency and skills of the mother who has been on the child-care leave for about 3 years. Based on the experts’ conclusions, full–fledged returning to professional environment takes about 6 months.”
Dina Nemirovych, Strategy Director of Farmak JSC:
“As defined in our corporate social responsibility strategy the Company’s key objective is to implement the best practices in human resources management. Farmak JSC seeks to establish the uttermost favourable conditions to implement the employees’ potential and improve their work effectiveness, including the possibility to combine the family duties and professional responsibilities.
Farmak JSC, a leader of domestic pharmaceutical market in a responsible manner treats the rights of the parents who are returning to work after being on the child-care leave. In Farmak JSC the right to take the child-care leave is exercised by the majority of the women which number as of 2012 amounts to 59% of the whole staff of 1924 employees. At present 67 employees are on the child-care leave. The rights of the employees who become the parents are preserved by the Collective Agreement and, moreover, the workplace is ensured for all of the employees who are returning to work, and, if needed, during the adaptation period they undergo the training and educational course.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...